Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. [electronic resource]
Producer: 20041130Description: 226-30 p. digitalISSN:- 0903-1936
- Acetates -- administration & dosage
- Administration, Inhalation
- Adult
- Aspirin -- adverse effects
- Asthma -- chemically induced
- Confidence Intervals
- Cross-Over Studies
- Cyclopropanes
- Cysteine -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Leukotrienes -- metabolism
- Lysine -- adverse effects
- Male
- Middle Aged
- Nasal Provocation Tests
- Peak Expiratory Flow Rate
- Quinolines -- administration & dosage
- Reference Values
- Reproducibility of Results
- Spirometry
- Sulfides
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.